Cure My Disease

Don't miss your cure!

 Log in / Sign up

New prosthetic control system put to the test in short study

NCT ID NCT07071584

Knowledge-focused Sponsor: Phantom Neuro Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests the Phantom X system, which uses muscle signals from the arm to control a prosthetic hand. Adults with below-elbow amputations will wear a non-invasive version for one day and perform simple tasks like moving blocks. They will compare it with their usual prosthesis and fill out surveys about their experience.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Started

Aug 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Individuals 21 years in age and older 2. Individuals with unilateral or bilateral amputation at transradial level 3. Patient is willing to comply with study protocol and make required study visits 4. Willingness and ability to sign Informed Consent Exclusion Criteria: 1. Cognitively impaired to follow study instructions 2. Allergies to skin adhesive materials necessary for cutaneous electrode placement 3. Excessive hair growth on arms and inability to shave off the hair for electrode placement 4. Pregnant woman 5. Residual limbs of insufficient diameter or length to accommodate the wearing of two cutaneous sensor arrays 6. Injuries, bruises, or open wounds on the arm that needs to be instrumented for the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Upper limb amputation below elbow are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Upper limb amputation below elbow

Contacts and locations

Locations

  • Atlas Ambulatory Surgery Center

    Buffalo, New York, 14221, United States

  • Phantom Neuro Inc. Operational Headquarters

    Austin, Texas, 78701, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.